What is aortic stenosis and why does it affect ethnic minority groups disproportionately?

Aortic stenosis is a condition where the aortic valve narrows, restricting blood flow from the heart. Evidence suggests that people from ethnic minority backgrounds are less likely to receive treatment for this condition after diagnosis.

How do the rapid access valve assessment clinics aim to reduce healthcare inequality?

These clinics are located in communities with high ethnic minority populations and historically lower treatment rates for valve disease. They aim to improve diagnosis and provide prompt treatment, thereby closing the healthcare gap.

What were the initial results of the pilot rapid access valve assessment clinics?

The six-month pilot screened 168 patients, with over half from minority ethnic backgrounds. A significant portion were found to have valve disease requiring treatment or further monitoring, indicating the program's effectiveness.

Home / Health / Heart Valve Clinics Bridge Ethnic Health Gap

Heart Valve Clinics Bridge Ethnic Health Gap

28 Jan

•

Summary

Pilot clinics target ethnic minority heart disease diagnosis.
Black patients 48% less likely to get valve replacement.
Program expansion urged to close healthcare inequality gap.

Heart Valve Clinics Bridge Ethnic Health Gap

Rapid access valve assessment clinics, piloted in south London, have demonstrated success in addressing healthcare inequalities for ethnic minority patients suffering from aortic stenosis. The condition, which narrows the aortic valve and restricts blood flow, affects an estimated 300,000 people in England.

Evidence indicates that individuals from ethnic minority backgrounds are less likely to receive treatment for aortic stenosis. A study revealed Black patients are 48% less likely, and South Asian patients 27% less likely, to undergo valve replacement procedures compared to white patients. This disparity has prompted the establishment of community clinics in areas with high ethnic minority populations and lower treatment rates.

The six-month pilot screened 168 patients, with over half from minority ethnic backgrounds. A significant percentage (57%) were found to have valve disease or other clinically relevant findings, with 35% requiring further treatment or surveillance. Based on these positive outcomes, medical professionals are advocating for the program's replication nationwide.